Detalhe da pesquisa
1.
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
Am J Hematol
; 96(1): E5-E8, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32974944